

































Two unexpected findings in Trpv1 knockout mice 
 
Recent studies have shown that transient receptor 
potential (TRP) channels, including the vanilloid-1 
channel (TRPV1), are involved in the regulation of 
multiple physiological functions in health and disease 
[1-3]. While studying  the thermoregulatory phenotype 
of mice genetically deficient in TRPV1 channels 
(Trpv1
-/-), we made two unexpected observations [4]. 
First, we found that young (age of ~17 wk; body mass 
of ~30 g) male Trpv1
-/- mice expressed a higher 
locomotor activity in a thermogradient apparatus, 
especially during the light (inactive) phase, as compared 
to their wild-type littermates (Trpv1
+/+). In this 
apparatus, each mouse could move freely inside a 200-
cm-long chamber with a linear ambient-temperature 
gradient from 20 to 30°C. The magnitude of the 
hyperactivity of Trpv1
-/- mice in this thermogradient 
apparatus was remarkable: at one time point  during  the  
 
 

































inactive phase (3:00 P.M.), Trpv1
-/- mice were moving 
with an average velocity of 85 cm/min (> 1.2 km/day), 
which was ~3 times higher than the average speed of 
wild-type mice at the same time of day. 
 
Our second unforeseen observation was that, with age, 
Trpv1
-/- mice of both sexes became heavier than their 
Trpv1
+/+ counterparts. For example, at the age of ~36 
wk, the body mass of male Trpv1
-/- mice was 14% 
higher than that of the age-matched male controls: 49 ± 
1 vs 43 ± 1 g (P < 1 x 10
-4). The two heaviest mice in 
our colony were Trpv1
-/- males: one had a body mass of 
59 g at the age of 35 wk, and the other weighed 58 g at 
61 wk. Even though we did not measure the amount of 
fat in aged Trpv1
-/- mice, their phenotype was consistent 
with obesity. The animals had larger bellies, which 
suggested visceral fat accumulation, a generally 
accepted hallmark of aging [5]. We also noticed both a 
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-/- mice  while 
performing surgeries for a different study (S. P. Wanner 
and A. A. Romanovsky, unpublished observations), as 
well as for the experiments reported in the present 
paper. 
 
Hyperactive when young  
 
The finding of increased locomotor activity of young 
Trpv1
-/- mice contradicts several studies showing that 
the deletion of the Trpv1 gene does not affect the 
locomotor activity [6-8]. However, all these studies 
used much shorter observation periods, sometimes as 
short as 15 min. Furthermore, even though these studies 
found no statistically significant differences in the 
locomotor activity of Trpv1
-/- mice, some of them 
showed strong tendencies that would agree with our 
results [4]. For example, Davis et al. [6] found that 
Trpv1
-/- mice tended to have higher scores in several 
activity tests. An increased activity of Trpv1
-/- mice was 
also observed by Marsch et al. [8] in tests for anxiety-
related behaviors. The increased spontaneous locomotor 
activity observed in our study [4] was unlikely to be due 
to changes in either anxiety or exploratory behavior, 
because the mice were extensively adapted to the 
experimental setups and were observed over long 
periods of time. Whether it  was related to changes in 
the sleep pattern is unknown, but at least one highly 
potent and selective TRPV1 antagonist, BCTC, did not 
affect sleep in the study by Takeda et al. [9]. We 
hypothesized that TRPV1 channels were involved in a 
mechanism inhibiting the locomotor activity. We then 
confirmed this hypothesis in pharmacological 
experiments using central and peripheral administration 
of TRPV1 agonists and an antagonist in both Trpv1
+/+ 
and Trpv1
-/- animals [4]. Hence, our experiments with 
genetic (Trpv1
-/- mice) and pharmacological tools 
suggest that TRPV1-mediated signals from the 
periphery tonically suppress general locomotor activity. 
Whether such suppression occurs due to a direct action 
on the locomotor system (i.e., on skeletal muscles or 
neural circuits involved in the locomotor control) or 
indirectly (e.g., by affecting motivation) remains to be 
elucidated. 
 
Overweight when aged 
 
Our second observation – the predisposition of Trpv1
-/- 
mice to age-associated overweight – was also 
unexpected. It contradicted the studies by Davis et al. 
[6], Rong et al. [10], and Zhang et al. [11], who all 
found no changes in the body mass of Trpv1
-/- mice 
compared to controls, when maintained on either a 
regular or high-fat diet. Our observations also 
contradicted the study by Motter and Ahern [12], in 
which Trpv1
-/- mice were found less prone to become 
obese on a high-fat diet compared to wild-type controls. 
However, all abovementioned studies used young mice 
with the body mass in a 10-30 g range (on a regular 
diet). In this body mass range, the intergenotype 
difference in our study was also small, but with age (we 
observed the mice up to the age of 61 wk), the 
difference increased [4]. Furthermore, even though a 
higher body mass in aged Trpv1
-/- mice was not reported 
previously, the obesity-protective role of TRPV1 
channels was proposed [11, 13] and supported by two 
lines of evidence. First, Zhang et al. [11] detected 
TRPV1 channels in preadipocytes, as well in murine 
and human visceral adipose tissue. These authors 
demonstrated TRPV1 downregulation during regular 
adipogenesis and found a reduced TRPV1 expression in 
visceral adipose tissue from obese mice and humans. 
Second, a long-term administration of capsaicin or 
capsinoids (nonpungent, capsaicin-related TRPV1 
agonists) was shown repeatedly to suppress visceral fat 
accumulation, produce thermogenesis, and prevent an 
increase in the body mass in laboratory animals and 
humans [11, 14-17], possibly by stimulating 
catecholamine secretion [18], decreasing appetite and 
food intake [19], and increasing fat oxidation [14]. 
Interestingly, the loss of abdominal fat in obese humans 
that occurred in response to capsinoid treatment in the 
study by Snitker et al. [14] was associated with the 
Val585Ile TRPV1 polymorphism: the subjects with the 
Val/Val and Val/Ile variants lost about twice as much 
abdominal fat as the study average, whereas Ile/Ile 
subjects lost none.  
 
Cumulatively, the studies reviewed above, support the 
hypothesis that TRPV1 channels protect from aging-
associated obesity. 
 
Hyperactive and overweight? Solving the paradox 
 
One paradox, however, remains unexplained. The 
association of locomotor hyperactivity (recorded at a 
younger age) with overweight (recorded at an older age) 
observed in our study [4] seems to contradict common 
sense. Obesity is known to be coupled with 
hyperactivity in certain pathological conditions, e.g., 
attention deficit hyperactivity disorder [20], but such 
coupling is rather an exception. To address this 
contradiction, we implanted miniature telemetry 
transmitters (G2 E-Mitter series; Mini Mitter) 
intraperitoneally in five aged male Trpv1
-/- mice (age: 
44 ± 1 wk; body mass: 50 ± 2 g) and five aged male 
Trpv1
+/+ littermates (age: 43 ± 1 wk; body mass: 44 ± 1 
g; all from the Amgen colony at Charles River 
Laboratories). All surgeries were performed as in our 
recent study [4], and all protocols were approved by the 
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Animal Care and Use Committee. On the third day after 
surgery, we measured the animals’ body mass and then 
placed them into a climatic chamber (model 3940; 
Forma Scientific) with ambient temperature set to 
28.0°C. In this setup, we studied their deep (abdominal) 
body temperature and locomotor activity for 48 h. The 
data obtained for each animal across the two days of 
observation were averaged and presented the means in 
Figure 1. The figure shows that the diurnal changes in 
body  temperature of  aged  Trpv1













































compared to their Trpv1
+/+ littermates, whereas their 
mean daily body temperature is unchanged. This is the 
same phenotype that was found in young Trpv1
-/- mice 
by Szelényi et al. [21] and, more recently, by Garami et 
al. [4]. However, even though the effects of the absence 
of TRPV1 channels on the body temperature of young 
and aged mice were the same, the effects on locomotor 
activity were the opposite. The gross locomotor activity 
of aged Trpv1
-/- mice was suppressed – not exaggerated 
– throughout the day, as compared to Trpv1
+/+ controls 
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above, we pooled together data from aged mice of both 
sexes, 14 Trpv1
-/- and 14 Trpv1
+/+, used in a different 
study (S. P. Wanner and A. A. Romanovsky, 
unpublished observations). These data are plotted in 
Figure 2. The age in the two groups was identical (42 ± 
1 wk), but the Trpv1
-/- were > 12% heavier than 
Trpv1
+/+ (48 ± 1 g vs. 43 ± 1 g; P = 1 x 10
-3). The 
locomotor activity of these animals was measured for 3 
h during the inactive phase (6:00-9:00 AM). This time 
period was chosen, because it corresponded to the 
maximum difference in the locomotor activity between 
aged  Trpv1
-/- and Trpv1
+/+ mice (Figure 1). The 
methods of animal preparation and measurements were 
identical to those used to produce the results presented 
in Figure 1, and the protocols were approved by the 
same committee. The 3-h measurements in the 
additional animals (Figure 2) have confirmed that the 
gross locomotor activity of aged Trpv1
-/- mice is 
suppressed as compared to Trpv1
+/+ controls (5 ± 1 and 






































Hence, the paradox of non-matching locomotor activity 
and body mass has now been solved. When Trpv1
-/- 
mice are young, they show increased levels of activity, 
at least in some experimental paradigms [4]; at this age, 
they show no obesity [4, 6, 10-12]. When Trpv1
-/- mice 
age, they become hypoactive (present observations) and 
overweight (compared to wild-type littermates), as has 
been shown in our previous study [4] and the present 
study. Why Trpv1
-/- animals are hyperactive at a young 
age, but then start moving less (and gain body mass) is 
unclear. A similar relationship, however, was reported 
for a group of healthy humans [22]. In that group, those 
individuals who were more physically active at a young 
age showed a higher mass gain 11 years later. What is 
becoming clear is that TRPV1 channels are intimately 
involved in the regulation of both general locomotor 
activity and body mass, and that TRPV1-mediated 
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